This week’s biotechnology news headlines include, clinical trials need more subjects, Medivation said to have rebuffed Sanofi takeover bid, Juno Therapeutics and WuXi AppTec to launch new biotech company, Sean Parker of Facebook and Napster to Start Cancer Immunotherapy Effort, Astra Zeneca and VentiRx partner on ovarian cancer vaccine trial, Allergan is partnering with heptares in Neurological Drug Alliance, and Boehringer’s Giotuf beats AstraZeneca’s Iressa in lung cancer trial.
Cell Culture Events
Webinars:
Bioprocess Insights Webinar Series:
Upstream – How to Improve Productivity and Process Economy Through Intensified Seed Train Strategies
Wed, Apr 20, 2016 – Time:11:00 AM EDT – Duration:30 minutes
Dr. Andreas Castan will discuss the upstream seed train and will show how a process intensification strategy can be used to compress timelines and decrease the cost for this unit operation.
Register Now.
BIO International Convention – June 6-9, 2016 – San Francisco, CA
http://convention.bio.org/Cell Line Development & Engineering – June 13-15, 2016 – Parc 55 Wyndham San Francisco, CA
http://www.ibclifesciences.com/CellLine/overview.xml
Co-located with
Bioconjugates: From Targets to Therapeutics – http://www.ibclifesciences.com/Bioconjugates/overview.xmlNext Generation Protein Therapeutics Summit – http://www.ibclifesciences.com/ProteinSummit/overview.xmlAnnual Meeting of the International Society for Stem Cell Research – June 22-25, 2016, San Francisco, CA
http://www.isscr.org/home/annual-meeting/san-francisco-2016Progress in Continuous Biomanufacturing – June 27-28, 2016 – Robinson College, Cambridge, UK
The conference is enhanced by the participation of several leading industrial technologists, scientific, vendors and also leading academics from Europe and USA. They have come forward to share their experience and knowledge to provide a better understanding of the current technologies and their application in continuous biomanufacturing. There is also a plenary lecture by a distinguished professor in the field of bioprocessing, and you will also benefit from access to unpublished data. This meeting will address several advancements and their successful application with data in the Technology both Upstream and downstream and also on Initiatives to process developments and project to the future direction of the industry. By joining with us you can benefit from the current state of-the-art advancements in continuous manufacturing and also learn about the successful organisations that are developing and applying these methods in-house.
http://www.subramanian.org.uk/Viral Safety and Raw Materials – June 2016, Vienna, Austria
http://www.informa-ls.com/event/empoweredantibodies15
“Medivation Inc. rebuffed a recent takeover approach from French drugmaker Sanofi, which is pursuing the U.S. company to expand its cancer treatment business, according to people familiar with the matter.”
If you like this story, please see our blog titled “Cool Tool – A Xeno-free Culture System for hMSC Isolation and Expansion”
“Sean Parker was a pioneer in music sharing when he co-founded Napster and in social media as the early president of Facebook. Now he wants to pioneer in a field that is already jumping with activity: cancer immunotherapy”
If you like this story, please see our blog titled “2015 FDA New Drug Approvals – 13 Biologics Receive Approval”
“AstraZeneca ($AZN) is stepping up its partnership with biotech VentiRx, the Ludwig Cancer Research and the Cancer Research Institute to begin further trials combining its PD-L1 drug with a TLR8 cancer vaccine as the Big Pharma company aims to push on with its cancer immunotherapy.”
If you like this story, please see our blog titled “Cool Tool – Producing 3D Tissue Models of the Airway Epithelium with PneumaCult™”
“Allergan is partnering with Heptares in an up-to-$3.3 billion R&D and commercialization collaboration to develop subtype-selective muscarinic receptor agonists for Alzheimer’s disease and other major neurological disorders.”
If you like this story, please see our blog titled “Cool Tools – BrainPhys™: A New Way to Culture Neurons”
“Boehringer Ingelheim’s Giotrif has beaten AstraZeneca’s Iressa on a number of clinical measures investigated in a head-to-head study involving patients with EGFR mutation-positive advanced non-small cell lung cancer.”
If you like this story, please see our blog titled “Enabling High Density Cell Banking using a Single-Use, Closed-System”
